Gut microbiome and renal transplantation

Area of Science:

• Microbiology
• Immunology
• Transplantation Medicine

Background:

• The gut microbiome plays a crucial role in human health, influencing the immune system.
• Kidney transplantation and associated treatments (immunosuppressants, antibiotics) significantly alter gut microbiome composition.
• Dysbiosis post-transplantation is linked to various complications, impacting graft and patient survival.

Purpose of the Study:

• To investigate the impact of gut microbiome changes on kidney transplant recipients.
• To explore the relationship between gut dysbiosis and post-transplant complications.
• To identify strategies for modulating the gut microbiome to improve outcomes.

Main Methods:

• Review of existing literature on gut microbiome alterations in kidney transplant patients.
• Analysis of the functional consequences of dysbiosis, including immune response and immunosuppressant metabolism.
• Exploration of therapeutic interventions targeting the gut microbiome.

Main Results:

• Kidney transplantation and immunosuppression disrupt the gut microbiome, leading to dysbiosis.
• Dysbiosis increases risks of graft rejection, infections, and metabolic disorders (e.g., post-transplant diabetes mellitus).
• Gut microbes affect immunosuppressant metabolism, potentially leading to underdosing and rejection.

Conclusions:

• Maintaining a healthy gut microbiome, rich in short-chain fatty acid (SCFA)-producing bacteria, is vital post-transplantation.
• Dietary modifications (high fiber), probiotics, and prebiotics can support beneficial gut bacteria.
• Microbiome modulation holds promise for improving metabolic compensation, inducing tolerance, and enhancing long-term patient and graft survival.